Chapter 31
Chapter 31
Chapter 31
Chapter 31
Chapter 31
100

Reduced motivation, interest, or emotional involvement in activities and surroundings.

Apathy
100

Medication-related movement disorders, especially associated with dopamine-blocking drugs, including akathisia, dystonia, parkinsonism, and tardive dyskinesia.

Extrapyramidal side effects (EPSEs)

100

Reductions in usual functioning, such as diminished emotional expression, motivation, speech, pleasure, or social engagement.

Negative symptoms

100

An involuntary, sustained or recurring deviation of the eyes, usually upward, caused by a dystonic muscle reaction.

Oculogyric crisis

100

Misinterpretations of actual sensory stimuli, such as mistaking a shadow for a person.

Illusions

200

Reduced amount, richness, or elaboration of thinking, often reflected in brief answers and limited spontaneous speech.

Poverty of thought

200

Difficulty recognizing familiar objects, people, or sounds despite adequate basic sensory functioning.

Agnosia

200

Interpreting unrelated events or remarks as having special personal meaning, without the fixed certainty of a delusion.

Ideas of reference

200

Absence or marked reduction of movement, including difficulty initiating voluntary movement.

Akinesia

200

Fixed beliefs maintained despite strong contradictory evidence and not explained by the person’s cultural or religious context.

Delusions

300

Involuntary spasms of the voice-box or throat muscles that can impair speaking, swallowing, or breathing; airway involvement is a medical emergency.

Laryngeal-pharyngeal dystonia

300

A state involving impaired reality testing, often with delusions, hallucinations, or markedly disorganized thinking.

Psychosis

300

Feeling that one’s surroundings are unreal, distant, dreamlike, or unfamiliar.

Derealization

300

Sensory experiences, such as hearing voices or seeing things, that occur without an external stimulus.

Hallucinations

300

Repeatedly continuing a word, idea, response, or action even after it is no longer appropriate or the subject has changed.

Perseveration

400

Difficulty identifying and describing one’s own emotions.

Alexithymia

400

Abnormally slow movement, often with reduced spontaneous movement.

Bradykinesia

400

A potentially persistent movement disorder associated with prolonged exposure to dopamine-blocking medications, often causing repetitive movements of the mouth, tongue, face, limbs, or trunk.

Tardive dyskinesia

400

Abnormal, involuntary movements, such as repetitive, twisting, or jerking motions.

Dyskinesia

400

Reduced ability to experience pleasure or interest in previously enjoyable activities.

Anhedonia

500

Involuntary muscle contractions that cause twisting movements or abnormal, sometimes painful postures.

Dystonia

500

A mental disorder involving disturbances in thinking, perception, emotional expression, motivation, and functioning, which may include episodes of psychosis.

Schizophrenia

500

Inner restlessness and a strong urge to move, often shown by pacing, rocking, or difficulty sitting still.

Akathisia

500

An abnormal twisting or tilting of the neck; in a medication-related dystonic reaction, it results from involuntary neck-muscle contractions.

Torticollis

500

Experiences or behaviors added to usual functioning, such as hallucinations, delusions, and disorganized speech or behavior.  

Positive symptoms

600

A rare, life-threatening reaction usually associated with antipsychotics, involving high fever, severe muscle rigidity, altered mental status, and unstable autonomic functions.

Neuroleptic malignant syndrome (NMS)

M
e
n
u